Correlation Between Connect Biopharma and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Merck Company, you can compare the effects of market volatilities on Connect Biopharma and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Merck.

Diversification Opportunities for Connect Biopharma and Merck

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Connect and Merck is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Merck go up and down completely randomly.

Pair Corralation between Connect Biopharma and Merck

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 3.84 times more return on investment than Merck. However, Connect Biopharma is 3.84 times more volatile than Merck Company. It trades about 0.1 of its potential returns per unit of risk. Merck Company is currently generating about 0.02 per unit of risk. If you would invest  105.00  in Connect Biopharma Holdings on September 12, 2024 and sell it today you would earn a total of  9.00  from holding Connect Biopharma Holdings or generate 8.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  Merck Company

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Connect Biopharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Connect Biopharma and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and Merck

The main advantage of trading using opposite Connect Biopharma and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Connect Biopharma Holdings and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios